Organization · Venture Capital
Fundamentum Capital
Fundamentum Capital is a US-based venture capital firm specializing in dual-use innovation, focusing on technologies applicable in both civilian and defense sectors. The firm targets growth-stage bioinnovation to address critical global challenges.
Overview
What Fundamentum Capital does
What Fundamentum Capital is
Fundamentum Capital is a US-based venture capital firm specializing in dual-use innovation, focusing on technologies applicable in both civilian and defense sectors. The firm targets growth-stage bioinnovation to address critical global challenges.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 25, 2026
Official channels
Find Fundamentum Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Fundamentum Capital as a funder
Investment thesis
Fundamentum Capital focuses on dual-use innovations that serve both civilian and military applications, particularly in the bioinnovation sector.
Focus narrative
The firm invests in dual-use technologies, targeting innovations that serve both civilian and military applications. While specific details on sectors and stages were not provided, the focus on growth-stage bioinnovation suggests an interest in advanced medical countermeasures and therapeutics.
Value beyond capital
Fundamentum Capital adds value through strategic partnerships and innovative deal structures, including optioned-rights agreements that allow for exclusive commercialization rights, positioning itself at the intersection of venture capital and strategic investment.
Focus and fit
- Stages
- Series B · Series B+
- Regions
- North America
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 1
Portfolio context
Currently, the only known portfolio company is Malaika Vx, with which Fundamentum Capital has a research and investment collaboration focused on developing a vaccine pipeline for bioterrorism, SARS, hemorrhagic fevers, and influenza.
Common questions
What to know about Fundamentum Capital
Upseed classifies Fundamentum Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 25, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.